位置:首页 > 蛋白库 > ZMYM5_HUMAN
ZMYM5_HUMAN
ID   ZMYM5_HUMAN             Reviewed;         669 AA.
AC   Q9UJ78; B2R6V1; Q5T6E1; Q5T6E2; Q5T6E4; Q96IY6; Q9NZY5; Q9UBW0; Q9UJ77;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 4.
DT   03-AUG-2022, entry version 153.
DE   RecName: Full=Zinc finger MYM-type protein 5;
DE   AltName: Full=Zinc finger protein 198-like 1;
DE   AltName: Full=Zinc finger protein 237;
GN   Name=ZMYM5; Synonyms=ZNF198L1, ZNF237; ORFNames=HSPC050;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3).
RX   PubMed=10894931; DOI=10.1159/000015584;
RA   Sohal J., Reiter A., Goldman J.M., Cross N.C.;
RT   "Cloning of ZNF237, a novel member of the MYM gene family that maps to
RT   human chromosome 13q11-->q12.";
RL   Cytogenet. Cell Genet. 89:24-28(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS VAL-125
RP   AND PHE-137.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS VAL-125
RP   AND PHE-137.
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 165-346.
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for 300
RT   previously undefined genes expressed in CD34+ hematopoietic stem/progenitor
RT   cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-455, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-88; LYS-91; LYS-134; LYS-149;
RP   LYS-166; LYS-225; LYS-443; LYS-455; LYS-462 AND LYS-552, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [11]
RP   STRUCTURE BY NMR OF 229-277.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of TRASH domain of zinc finger MYM-type protein 5.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [12]
RP   INTERACTION WITH ETV5, FUNCTION, AND MUTAGENESIS OF ASN-112; SER-114;
RP   THR-116 AND ASP-120.
RX   PubMed=17126306; DOI=10.1016/j.brainres.2006.10.056;
RA   Pastorcic M., Das H.K.;
RT   "Analysis of transcriptional modulation of the presenilin 1 gene promoter
RT   by ZNF237, a candidate binding partner of the Ets transcription factor
RT   ERM.";
RL   Brain Res. 1128:21-32(2007).
CC   -!- FUNCTION: Functions as a transcriptional regulator.
CC       {ECO:0000269|PubMed:17126306}.
CC   -!- SUBUNIT: Interacts (via N-terminal 120 amino acid region) with ETV5
CC       (via C-terminal). {ECO:0000269|PubMed:17126306}.
CC   -!- INTERACTION:
CC       Q9UJ78; P63165: SUMO1; NbExp=4; IntAct=EBI-7228860, EBI-80140;
CC       Q9UJ78-2; Q13554-3: CAMK2B; NbExp=3; IntAct=EBI-17634549, EBI-11523526;
CC       Q9UJ78-2; Q9H257-2: CARD9; NbExp=3; IntAct=EBI-17634549, EBI-11530605;
CC       Q9UJ78-2; P35520: CBS; NbExp=3; IntAct=EBI-17634549, EBI-740135;
CC       Q9UJ78-2; P17661: DES; NbExp=3; IntAct=EBI-17634549, EBI-1055572;
CC       Q9UJ78-2; Q13158: FADD; NbExp=3; IntAct=EBI-17634549, EBI-494804;
CC       Q9UJ78-2; Q6NT76: HMBOX1; NbExp=3; IntAct=EBI-17634549, EBI-2549423;
CC       Q9UJ78-2; Q86YM7: HOMER1; NbExp=3; IntAct=EBI-17634549, EBI-746815;
CC       Q9UJ78-2; Q5TA77: LCE3B; NbExp=3; IntAct=EBI-17634549, EBI-11974495;
CC       Q9UJ78-2; Q02548: PAX5; NbExp=3; IntAct=EBI-17634549, EBI-296331;
CC       Q9UJ78-2; Q92734: TFG; NbExp=3; IntAct=EBI-17634549, EBI-357061;
CC       Q9UJ78-2; Q12933: TRAF2; NbExp=3; IntAct=EBI-17634549, EBI-355744;
CC       Q9UJ78-2; Q9BUZ4: TRAF4; NbExp=3; IntAct=EBI-17634549, EBI-3650647;
CC       Q9UJ78-2; Q15645: TRIP13; NbExp=3; IntAct=EBI-17634549, EBI-358993;
CC       Q9UJ78-2; Q9UMX0: UBQLN1; NbExp=3; IntAct=EBI-17634549, EBI-741480;
CC       Q9UJ78-2; Q9HCK0: ZBTB26; NbExp=3; IntAct=EBI-17634549, EBI-3918996;
CC       Q9UJ78-2; O60232: ZNRD2; NbExp=3; IntAct=EBI-17634549, EBI-741415;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=4;
CC         IsoId=Q9UJ78-4; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q9UJ78-1; Sequence=VSP_034646, VSP_034647;
CC       Name=2;
CC         IsoId=Q9UJ78-2; Sequence=VSP_011443, VSP_011444;
CC       Name=3;
CC         IsoId=Q9UJ78-3; Sequence=VSP_011442, VSP_011445;
CC       Name=5;
CC         IsoId=Q9UJ78-5; Sequence=VSP_034645;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF29022.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ133352; CAB57262.1; -; mRNA.
DR   EMBL; AJ133353; CAB57263.1; -; mRNA.
DR   EMBL; AJ133355; CAB57265.1; -; mRNA.
DR   EMBL; AJ133354; CAB57264.1; -; mRNA.
DR   EMBL; BT006687; AAP35333.1; -; mRNA.
DR   EMBL; AK312724; BAG35598.1; -; mRNA.
DR   EMBL; AL354808; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355001; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08238.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08240.1; -; Genomic_DNA.
DR   EMBL; BC007048; AAH07048.1; -; mRNA.
DR   EMBL; AF161535; AAF29022.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS31942.1; -. [Q9UJ78-1]
DR   CCDS; CCDS31943.1; -. [Q9UJ78-2]
DR   RefSeq; NP_001034738.1; NM_001039649.2. [Q9UJ78-2]
DR   RefSeq; NP_001034739.1; NM_001039650.2. [Q9UJ78-1]
DR   RefSeq; NP_001136156.1; NM_001142684.1. [Q9UJ78-4]
DR   RefSeq; XP_005266650.1; XM_005266593.3. [Q9UJ78-4]
DR   RefSeq; XP_005266651.1; XM_005266594.2. [Q9UJ78-4]
DR   RefSeq; XP_006719957.1; XM_006719894.2. [Q9UJ78-4]
DR   PDB; 2DAS; NMR; -; A=229-277.
DR   PDBsum; 2DAS; -.
DR   AlphaFoldDB; Q9UJ78; -.
DR   SMR; Q9UJ78; -.
DR   BioGRID; 114639; 31.
DR   IntAct; Q9UJ78; 27.
DR   MINT; Q9UJ78; -.
DR   STRING; 9606.ENSP00000372361; -.
DR   iPTMnet; Q9UJ78; -.
DR   PhosphoSitePlus; Q9UJ78; -.
DR   BioMuta; ZMYM5; -.
DR   DMDM; 212288108; -.
DR   EPD; Q9UJ78; -.
DR   jPOST; Q9UJ78; -.
DR   MassIVE; Q9UJ78; -.
DR   MaxQB; Q9UJ78; -.
DR   PaxDb; Q9UJ78; -.
DR   PeptideAtlas; Q9UJ78; -.
DR   PRIDE; Q9UJ78; -.
DR   ProteomicsDB; 84596; -. [Q9UJ78-4]
DR   ProteomicsDB; 84597; -. [Q9UJ78-1]
DR   ProteomicsDB; 84598; -. [Q9UJ78-2]
DR   ProteomicsDB; 84599; -. [Q9UJ78-3]
DR   ProteomicsDB; 84600; -. [Q9UJ78-5]
DR   Antibodypedia; 22270; 37 antibodies from 13 providers.
DR   DNASU; 9205; -.
DR   Ensembl; ENST00000337963.9; ENSP00000337034.4; ENSG00000132950.19. [Q9UJ78-4]
DR   Ensembl; ENST00000382905.8; ENSP00000372361.4; ENSG00000132950.19. [Q9UJ78-1]
DR   Ensembl; ENST00000382907.8; ENSP00000372364.4; ENSG00000132950.19. [Q9UJ78-2]
DR   GeneID; 9205; -.
DR   KEGG; hsa:9205; -.
DR   MANE-Select; ENST00000337963.9; ENSP00000337034.4; NM_001142684.2; NP_001136156.1.
DR   UCSC; uc001umn.4; human. [Q9UJ78-4]
DR   CTD; 9205; -.
DR   DisGeNET; 9205; -.
DR   GeneCards; ZMYM5; -.
DR   HGNC; HGNC:13029; ZMYM5.
DR   HPA; ENSG00000132950; Low tissue specificity.
DR   MIM; 616443; gene.
DR   neXtProt; NX_Q9UJ78; -.
DR   OpenTargets; ENSG00000132950; -.
DR   PharmGKB; PA37607; -.
DR   VEuPathDB; HostDB:ENSG00000132950; -.
DR   eggNOG; ENOG502S9U9; Eukaryota.
DR   GeneTree; ENSGT00940000162379; -.
DR   HOGENOM; CLU_026638_0_1_1; -.
DR   InParanoid; Q9UJ78; -.
DR   OMA; EHCGEYM; -.
DR   OrthoDB; 537563at2759; -.
DR   PhylomeDB; Q9UJ78; -.
DR   PathwayCommons; Q9UJ78; -.
DR   SignaLink; Q9UJ78; -.
DR   BioGRID-ORCS; 9205; 10 hits in 1083 CRISPR screens.
DR   ChiTaRS; ZMYM5; human.
DR   EvolutionaryTrace; Q9UJ78; -.
DR   GenomeRNAi; 9205; -.
DR   Pharos; Q9UJ78; Tdark.
DR   PRO; PR:Q9UJ78; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q9UJ78; protein.
DR   Bgee; ENSG00000132950; Expressed in buccal mucosa cell and 180 other tissues.
DR   Genevisible; Q9UJ78; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:GO_Central.
DR   InterPro; IPR011017; TRASH_dom.
DR   InterPro; IPR010507; Znf_MYM.
DR   Pfam; PF06467; zf-FCS; 3.
DR   SMART; SM00746; TRASH; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Isopeptide bond; Metal-binding;
KW   Nucleus; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..669
FT                   /note="Zinc finger MYM-type protein 5"
FT                   /id="PRO_0000191380"
FT   ZN_FING         265..299
FT                   /note="MYM-type 1"
FT   ZN_FING         311..351
FT                   /note="MYM-type 2"
FT   ZN_FING         358..393
FT                   /note="MYM-type 3"
FT   ZN_FING         404..431
FT                   /note="MYM-type 4"
FT   CROSSLNK        88
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        91
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        134
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        149
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        166
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        225
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        443
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        455
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        462
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        552
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..176
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_034645"
FT   VAR_SEQ         165..213
FT                   /note="TKTGVRPFNPGRMNVAGDLFQNGEFATHHSPDSWISQSASFPSNQKQPG ->
FT                   VNAGMGNSGITTELTLKYIITNVTTLETGISSVNAGQDVNIIITYKTSL (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10894931,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_011442"
FT   VAR_SEQ         196..208
FT                   /note="DSWISQSASFPSN -> EMHLQRRLMSFFQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10894931,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.2"
FT                   /id="VSP_011443"
FT   VAR_SEQ         209..669
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10894931,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.2"
FT                   /id="VSP_011444"
FT   VAR_SEQ         214..669
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10894931,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_011445"
FT   VAR_SEQ         347..382
FT                   /note="IRHEVSVNNVTHKLCSNHCFNKYRLANGLIMNCCEH -> VWIFIPKLLFRL
FT                   TVIILTFKCYYVLFHLHNARVLDV (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:10894931"
FT                   /id="VSP_034646"
FT   VAR_SEQ         383..669
FT                   /note="Missing (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:10894931"
FT                   /id="VSP_034647"
FT   VARIANT         125
FT                   /note="I -> V (in dbSNP:rs9579718)"
FT                   /evidence="ECO:0000269|PubMed:15489334, ECO:0000269|Ref.2"
FT                   /id="VAR_025508"
FT   VARIANT         137
FT                   /note="C -> F (in dbSNP:rs9579717)"
FT                   /evidence="ECO:0000269|PubMed:15489334, ECO:0000269|Ref.2"
FT                   /id="VAR_025509"
FT   VARIANT         231
FT                   /note="T -> A (in dbSNP:rs41292167)"
FT                   /id="VAR_062160"
FT   MUTAGEN         112
FT                   /note="N->H: Abolishes interaction with ETV5. Abolished
FT                   repression activity."
FT                   /evidence="ECO:0000269|PubMed:17126306"
FT   MUTAGEN         114
FT                   /note="S->G: Abolishes interaction with ETV5. No effect on
FT                   repression activity."
FT                   /evidence="ECO:0000269|PubMed:17126306"
FT   MUTAGEN         116
FT                   /note="T->A: No effect on repression activity."
FT                   /evidence="ECO:0000269|PubMed:17126306"
FT   MUTAGEN         120
FT                   /note="D->G: Increases repression activity."
FT                   /evidence="ECO:0000269|PubMed:17126306"
FT   CONFLICT        210
FT                   /note="K -> R (in Ref. 7; AAF29022)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        214
FT                   /note="V -> M (in Ref. 7; AAF29022)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        286
FT                   /note="S -> A (in Ref. 7; AAF29022)"
FT                   /evidence="ECO:0000305"
FT   TURN            245..247
FT                   /evidence="ECO:0007829|PDB:2DAS"
FT   STRAND          266..269
FT                   /evidence="ECO:0007829|PDB:2DAS"
FT   HELIX           270..276
FT                   /evidence="ECO:0007829|PDB:2DAS"
SQ   SEQUENCE   669 AA;  74817 MW;  3365CE4EFB8D73A9 CRC64;
     MEKCSVGGLE LTEQTPALLG NMAMATSLMD IGDSFGHPAC PLVSRSRNSP VEDDDDDDDV
     VFIESIQPPS ISAPAIADQR NFIFASSKNE KPQGNYSVIP PSSRDLASQK GNISETIVID
     DEEDIETNGG AEKKSSCFIE WGLPGTKNKT NDLDFSTSSL SRSKTKTGVR PFNPGRMNVA
     GDLFQNGEFA THHSPDSWIS QSASFPSNQK QPGVDSLSPV ALLRKQNFQP TAQQQLTKPA
     KITCANCKKP LQKGQTAYQR KGSAHLFCST TCLSSFSHKR TQNTRSIICK KDASTKKANV
     ILPVESSKSF QEFYSTSCLS PCENNWNLKK GVFNKSRCTI CSKLAEIRHE VSVNNVTHKL
     CSNHCFNKYR LANGLIMNCC EHCGEYMPSK STGNNILVIG GQQKRFCCQS CINEYKQMME
     TKSKKLTASE NRKRNAFREE NEKQLYGSSN TLLKKIEGIP EKKEKTSQLQ LSVECGTDTL
     LIQENVNLPP SSTSTIADTF QEQLEEKNFE DSIVPVVLSA DPGTWPRILN IKQRDTLVEN
     VPPQVRNFNF PKDNTGRKFS ETYYTRILPN GEKTTRSWLL YSTSKDSVFC LYCKLFGEGK
     NQLKNENGCK DWQHLSHILS KHEESEMHVN NSVKYSKLKS DLKKNKAIDA AEHRLYENEK
     NDGVLLLYT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024